
Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.

Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.

October 1st 2004
